Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinoma

被引：0
|
作者：
Johnson, M. L.
Sima, C.
Paik, P. K.
Janjigian, Y. Y.
Pao, W.
Kris, M. G.
Ladanyi, M.
Riely, G. J.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.7541
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7541
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas
    Johnson, Melissa L.
    Sima, Camelia S.
    Chaft, Jamie
    Paik, Paul K.
    Pao, William
    Kris, Mark G.
    Ladanyi, Marc
    Riely, Gregory J.
    [J]. CANCER, 2013, 119 (02) : 356 - 362
  • [2] EGFR and KRAS mutations are molecular predictors of survival in resected lung adenocarcinoma
    Marks, Jenifer L.
    Broderick, Stephen
    Seshan, Venkatraman E.
    Zakowski, Maureen F.
    Li, Allan
    Wilson, Richard
    Kris, Mark G.
    Ladanyi, Mark
    Rusch, Valerie W.
    Pao, William
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S480 - S481
  • [3] KRAS and EGFR mutations coexisting in lung adenocarcinoma
    Vitor Sousa
    Ana Alarcão
    Patricia Couceiro
    Maria R Silva
    Maria J d’Aguiar
    Lia Teixeira
    Lina Carvalho
    [J]. BMC Proceedings, 4 (Suppl 2)
  • [4] EGFR Mutations in Asian Patients with Advanced Lung Adenocarcinoma
    Liam, Chong-Kin
    Pang, Yong-Kek
    Poh, Mau-Ern
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : E70 - E71
  • [5] Prognostic and Predictive Implications of EGFR Mutations, EGFR Copy Number and KRAS Mutations in Advanced Stage Lung Adenocarcinoma
    Bonanno, Laura
    Schiavon, Marco
    Nardo, Giorgia
    Bertorelle, Roberta
    Bonaldi, Laura
    Galligioni, Alessandra
    Indraccolo, Stefano
    Pasello, Giulia
    Rea, Federico
    Favaretto, Adolfo
    [J]. ANTICANCER RESEARCH, 2010, 30 (12) : 5121 - 5128
  • [6] Prevalence of KRAS and Concomitant Mutations in Advanced Lung Adenocarcinoma Patients
    Gil Ferreira, C.
    Montella, T.
    Moreira De Sousa, C.
    Zalis, M.
    Aran, V.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1214 - S1214
  • [7] Evaluation of KRAS Concomitant Mutations in Advanced Lung Adenocarcinoma Patients
    Aran, Veronica
    Zalis, Mariano
    Montella, Tatiane
    de Sousa, Carlos Augusto Moreira
    Ferrari, Bruno L.
    Gil Ferreira, Carlos
    [J]. MEDICINA-LITHUANIA, 2021, 57 (10):
  • [8] Impact of EGFR and KRAS mutations on survival in 1,000 patients with resected lung adenocarcinoma.
    D'Angelo, S. P.
    Janjigian, Y. Y.
    Kris, M. G.
    Pao, W.
    Riely, G. J.
    Marks, J.
    Sima, C.
    Dycoco, J.
    Park, B. J.
    Azzoli, C. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] EGFR and KRAS Mutations in Lung Parenchyma of Subjects With EGFR/KRAS Wild-Type Lung Adenocarcinoma
    Chalela, Roberto
    Gonzalez-Garcia, Jose Gregorio
    Khilzi, Karys
    Curull, Victor
    Sanchez-Font, Albert
    Longaron, Raquel
    Rodrigo-Calvo, Maria Teresa
    Martin-Ontiyuelo, Clara
    Gea, Joaquim
    Bellosillo, Beatriz
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [10] Association between human papillomavirus and EGFR mutations in advanced lung adenocarcinoma
    Li, Ming
    Deng, Fang
    Qian, Li-Ting
    Meng, Shui-Ping
    Zhang, Yang
    Shan, Wu-Lin
    Zhang, Xiao-Lei
    Wang, Bao-Long
    [J]. ONCOLOGY LETTERS, 2016, 12 (03) : 1953 - 1958
12345